PO.PR01.03 · 预防研究
持续性高级别癌前病变中p21+细胞的积聚及生长停滞特征的富集
Accumulation of p21+ cells and enrichment of growth arrest signature in persistent high-grade premalignant lesions
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:肺鳞状细胞癌之前存在癌前病变(PML)或不典型增生,其可能持续、进展或消退。与病变消退者相比,持续性PML的个体发生癌症的风险显著更高。因此,控制不典型增生转归的机制对早期检测和预防可能具有重要意义。上皮基底祖细胞对维持健康气道至关重要,但其在决定PML转归中的作用此前尚未被研究。
方法:从高危个体采集的支气管内活检组织中培养的基底祖细胞,被检测其自我更新和多能分化的基本特征。采用细胞学、功能学和分子学分析相结合的方法,包括突变分析和单细胞(sc)RNAseq,以研究祖细胞功能及其在决定PML转归中的作用。
结果:随着不典型增生级别的加重,祖细胞功能下降,且祖细胞自我更新能力差可预测不典型增生的持续及向癌症的进展。对高自我更新和低自我更新祖细胞的突变分析未检测到总体突变负荷(包括致癌突变)方面的任何有意义的差异。有趣的是,与高自我更新祖细胞相比,低自我更新祖细胞中表达细胞周期蛋白依赖性激酶抑制剂(CDKN1A)或p21的细胞数量增加。活检组织的单细胞(sc)RNA-seq显示,在祖细胞自我更新能力低的病变中,表达p21的基底细胞富集。对PML进行的VECTRA多重免疫荧光染色证实,持续性病变中p21+细胞数量显著更多,且p21+细胞的丰度随时间增加。将多重免疫染色图像与从同一活检连续切片生成的VISIUM空间转录组图谱进行整合,实现了p21蛋白表达与相应转录组特征的直接对齐。对来自4个PML的6个p21高表达区域与p21低表达区域进行的spot水平差异分析显示,p21高表达spot中富集了特定通路(初级纤毛、细胞周期停滞、DNA损伤应答、代谢重编程和免疫参与)。
结论:p21是细胞周期进展的关键决定因素,该分子表达增加提示通过诱导短暂的G0状态而发生生长停滞。在含有低自我更新祖细胞的PML中发现p21+细胞,以及空间分析证实在多个高级别PML的p21高表达区域中存在细胞周期停滞特征,均提示这些通路在决定PML转归中发挥作用。未来的研究将聚焦于在具有已知持续、进展和消退自然史的独立PML中分析这些特征。
查看英文原文 English abstract
Introduction: Lung squamous cell carcinoma is preceded by premalignant lesions (PML) or dysplasia that may persist, progress, or regress. Individuals with persistent PMLs have a significantly higher risk of incident cancer compared to those whose lesions regress. Mechanisms that control dysplasia fate, therefore, could be important for early detection and prevention. Epithelial basal progenitors are critical for maintaining a healthy airway, but their role in determining PML fate has not been studied before.
Methods: Basal progenitors grown from endobronchial biopsies collected from high-risk individuals were assayed for their cardinal features of self-renewal and multipotent differentiation. A combination of cellular, functional, and molecular analyses, including mutations and single-cell (sc) RNAseq, was used to investigate progenitor function and their roles in determining PML fate.
Results: Progenitor function decreased with worsening dysplasia grade, and poor progenitor self-renewal predicted dysplasia persistence and progression to cancer. Mutational analysis of high- and low-self-renewing progenitors did not detect any meaningful difference in overall mutational burden, including oncogenic mutations. Interestingly, there were increased numbers of cells expressing cyclin-dependent kinase inhibitor (CDKN1A) or p21 in the progenitors with low self-renewal compared to those with high self-renewal. Single-cell (sc) RNA-seq of biopsies revealed enrichment of p21-expressing basal cells in lesions with low progenitor self-renewal. VECTRA multiplexed immunofluorescence staining of PMLs confirmed significantly greater numbers of p21+ cells in persistent lesions, and the abundance of p21+ cells increased over time. Integration of the multiplexed immunostaining images with the VISIUM spatial transcriptomic profiles generated from serial sections of the same biopsies allowed for direct alignment of p21 protein expression and the corresponding transcriptomic features. A spot-level differential analysis between six p21 high and p21 low regions from four PMLs revealed the enrichment of specific pathways (primary cilium, cell-cycle arrest, DNA damage responses, metabolic rewiring, and immune engagement) in p21 high spots.
Conclusions: p21 is a key determinant of cell cycle progression, and increased expression of this molecule indicates growth arrest by induction of a transient G0 state. The discovery of p21+ cells in PMLs containing low self-renewing progenitors and spatial analyses confirming the presence of a cell-cycle arrest signature in the p21 high areas in multiple high-grade PMLs indicated a role of these pathways in determining PML fate. Future studies will focus on analyzing these signatures in independent PMLs with a known natural history of persistence, progression, and regression.
利益披露 Disclosure
A. Assante, None..
K. Lkhagvadorj, None..
H. Kim, None..
K. R. Jordan, None..
D. T. Merrick, None..
R. L. Keith, None..
Y. E. Miller, None..
M. Ghosh, None.